Veracyte (VCYT) Cash from Financing Activities (2012 - 2026)
Veracyte's (VCYT) quarterly Cash from Financing Activities came in at -$6.6 million in Q1 2026, down 2.24% year-on-year from -$6.8 million in Q1 2025, and down 4348.99% quarter-over-quarter from -$149000.0 in Q4 2025.
Veracyte (VCYT) Cash from Financing Activities (2012 - 2026) Analysis & Trends
Veracyte has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$6.6 million for Q1 2026.
- Cash from Financing Activities for Q1 2026 came in at -$6.6 million, down 2.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$4.4 million (down 509.92% YoY), and the FY2025 annual result was -$4.2 million, down 186.09% from the prior year.
- Cash from Financing Activities came in at -$6.6 million for Q1 2026 at Veracyte, down from -$149000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $10.3 million in Q3 2024 to a low of -$6.6 million in Q1 2026.
- The 5-year median for Cash from Financing Activities is $93000.0 (2022), against an average of $22588.2.
- Across the five-year window, Cash from Financing Activities surged 9253.64% in 2024 and slumped 5045.45% in 2025, its largest moves.
- Veracyte's Cash from Financing Activities stood at $93000.0 in 2022, then soared by 593.55% to $645000.0 in 2023, then plunged by 799.22% to -$4.5 million in 2024, then soared by 96.7% to -$149000.0 in 2025, then sank by 4348.99% to -$6.6 million in 2026.
- The last three Cash from Financing Activities figures came in at -$6.6 million (Q1 2026), -$149000.0 (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | -213.00 Mn |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 1.09 Bn |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | 46.00 Mn |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | -211.43 Mn |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | -144.00 Mn |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | -433.00 Mn |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | 3.76 Mn |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | -251.00 Mn |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | -114.33 Mn |
| 10 | Veracyte | 3.76 Bn | 3.50 Bn | 101.16 Mn | -6.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -6.63 Mn |
| Mar 31, 2026 | -6.63 Mn |
| Dec 31, 2025 | -149,000.00 |
| Dec 31, 2025 | -149,000.00 |
| Sep 30, 2025 | 2.98 Mn |
| Sep 30, 2025 | 2.98 Mn |
| Jun 30, 2025 | -566,000.00 |
| Jun 30, 2025 | -566,000.00 |
| Mar 31, 2025 | -6.48 Mn |
| Mar 31, 2025 | -6.48 Mn |
| Dec 31, 2024 | -4.51 Mn |
| Dec 31, 2024 | -4.51 Mn |
| Sep 30, 2024 | 10.29 Mn |
| Sep 30, 2024 | 10.29 Mn |
| Jun 30, 2024 | -11,000.00 |
| Jun 30, 2024 | -11,000.00 |
| Mar 31, 2024 | -864,000.00 |
| Mar 31, 2024 | -864,000.00 |
| Dec 31, 2023 | 645,000.00 |
| Dec 31, 2023 | 645,000.00 |